Takeda, M., Okamoto, I., & Nakagawa, K. (2014). Survival Outcome Assessed According to Tumor Response and Shrinkage Pattern in Patients with EGFR Mutation–Positive Non–Small-Cell Lung Cancer Treated with Gefitinib or Erlotinib. Lippincott Williams & Wilkins.
シカゴスタイル引用形Takeda, Masayuki, Isamu Okamoto, , Kazuhiko Nakagawa. Survival Outcome Assessed According to Tumor Response and Shrinkage Pattern in Patients With EGFR Mutation–Positive Non–Small-Cell Lung Cancer Treated With Gefitinib or Erlotinib. Lippincott Williams & Wilkins, 2014.
MLA引用形式Takeda, Masayuki, Isamu Okamoto, , Kazuhiko Nakagawa. Survival Outcome Assessed According to Tumor Response and Shrinkage Pattern in Patients With EGFR Mutation–Positive Non–Small-Cell Lung Cancer Treated With Gefitinib or Erlotinib. Lippincott Williams & Wilkins, 2014.